E1/E2 capsid-protein targeting VLP vaccine (Compass Biotechnologies/C-Pharma)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameE1/E2 capsid-protein targeting VLP vaccine (Compass Biotechnologies/C-Pharma)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCompass Biotechnologies Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCompass Biotechnologies Inc C-Pharma

Active IndicationsN/A

Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A